| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,089 |
6,154 |
$516K |
| 98966 |
|
3,253 |
2,878 |
$146K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,182 |
1,157 |
$116K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,097 |
1,012 |
$100K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
994 |
883 |
$99K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
611 |
591 |
$60K |
| 99072 |
|
4,743 |
4,126 |
$23K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
155 |
153 |
$16K |
| 99080 |
|
1,410 |
1,277 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,087 |
533 |
$13K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
215 |
214 |
$7K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
700 |
684 |
$7K |
| 90686 |
|
285 |
280 |
$6K |
| 90723 |
|
229 |
221 |
$5K |
| 94760 |
|
1,876 |
1,707 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
332 |
310 |
$4K |
| 90647 |
|
159 |
157 |
$3K |
| 99401 |
|
73 |
71 |
$3K |
| A7037 |
Tubing used with positive airway pressure device |
87 |
82 |
$3K |
| 96127 |
|
446 |
441 |
$2K |
| D0190 |
|
135 |
135 |
$2K |
| 90670 |
|
79 |
79 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
87 |
82 |
$1K |
| 90633 |
|
68 |
66 |
$1K |
| 94664 |
|
75 |
70 |
$1K |
| 87807 |
|
96 |
95 |
$914.43 |
| 90715 |
|
41 |
41 |
$878.40 |
| 96160 |
|
265 |
187 |
$836.67 |
| 0072A |
|
15 |
15 |
$600.00 |
| 0071A |
|
14 |
13 |
$520.00 |
| 90672 |
|
16 |
16 |
$351.36 |
| 96161 |
|
116 |
113 |
$290.98 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
26 |
24 |
$2.28 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
26 |
26 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
486 |
462 |
$0.00 |
| 91307 |
|
34 |
31 |
$0.00 |
| 99000 |
|
14 |
13 |
$0.00 |